Additionally, a significant decrease in the p-Akt (Ser473)/Akt protein levels was observed in NSCLC cells treated with 50 μM of SM-3 after 24 h, compared to the Res-treated cells. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.